Control of lymphocyte function through CD27-CD70 interactions

Seminars in Immunology

Volumn 10, Issue 6, 1998, Pages 491-499

  Lens, Susanne M A ^a,b   Tesselaar, Kiki ^c   Van Oers, Marinus H J ^b   Van Lier, René A W ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

CD27; CD70; Lymphocytes; TNFR family

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; B CELL LEUKEMIA; B LYMPHOCYTE; BODY FLUID; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0032392095     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0154     Document Type: Article

References (89)

1. 1. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187
2. 2 MacLennan IC, Liu YJ, Johnson GD (1992) Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immun Rev 126:143-161
3. 3. Kelsoe G (1996) Life and death in germinal centers (Redux). Immunity 4:107-111
4. 4. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML (1997) IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159:28-35
5. 5. Trinchieri G (1998) Proinflammatory and immunoregulatory funcions of interleukin-12. Int Rev Immunol 16:365-396
6. 6. Gruss HJ, Dower SK (1995) Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378-3404
7. 7. Lotz M, Setareh M, Kempis vJ, Schwarz H (1996) The nerve growth factor/tumor necrosis factor receptor family. J Leuk Biol 60:1-7
8. 8. van Lier RAW, Borst J, Vroom ThM, Klein H, van Mourik P, Zeijlemaker WP, Melief CJM (1987) Tissue distribution and functional properties of Tp55(CD27), a novel T cell differentiation antigen. J Immunol 139:1589-1596
9. 9. Camerini D, Walz G, Loenen WAM, Borst J, Seed B (1991) The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 147:3165-3169
10. 10. Gravestein LA, Blom B, Nolten LA, de Vries E, van der Horst G, Ossendorp F, Borst J, Loenen WAM (1993) Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte specific member of the nerve growth factor receptor family. Eur J Immunol 23:943-950
11. 11. Borst J, Sluyser C, de Vries E, Klein H, Melief CJM, van Lier RAW (1989) Alternative molecular form of human T cell specific antigen CD27 expressed upon T cell activation. Eur J Immunol 19:357-364
12. 12. Loenen WAM, de Vries E, Gravestein LA, Hintzen RQ, van Lier RAW, Borst J (1992) The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol 22:447-455
13. 13. Hintzen RQ, de Jong R, Hack CE, Chamuleau M, De Vries EFR, ten Berge IJM, Borst J, van Lier RAW (1991) A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol 147:29-35
14. 14. Goodwin RG, Alderson MR, Smith CA, Armitage RJ, Vandenbos T, Jerzy R, Tough TW, Schoenborn M, Davis-Smith T, Hennen K, Falk B, Cosman D, Baker E, Sutherland GR, Grabstein KH, Farrah T, Giri JG, Beckmann MP (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447-456
15. 15. Hintzen RQ, Lens SMA, Lammers K, Kuiper H, Beckmann MP, Goodwin RG, van Lier RAW (1995) Engagement of CD27 with its ligand (CD70) provides a second signal for T-cell activation. J Immunol 154:2612-2623
16. 16. Bowman MR, Crimmins MAV, Yetz-Aldape J, Kriz R, Kelleher K, Herrmann S (1994) The cloning of CD70 and its identification as the ligand for CD27. J Immunol 152: 1756-1761
17. + naive T cell costimulation. J Immunol 153:5422-5432
18. 18. Gravestein LA, Nieland JD, Kruisbeek AM, Borst J (1995) Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int Immunol 7:551-557
19. 19. June CH, Ledbetter JA, Linsley PS, Thompson CB (1990) Role of the CD28 receptor in T-cell activation. Immunol Today 11:211-216
20. + T lymphocytes. J Immunol 154:3686-3695
21. 21. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87-98
22. 22. Sugita K, Torimoto Y, Nojima Y, Daley JF, Schlossman SF, Morimoto C (1991) The 1A4 molecule (CD27) is involved in T cell activation. J Immunol 147:1477-1483
23. 23. Agematsu K, Kobata T, Yang FC, Nakazawa T, Fukushima K, Kitahara M, Mori T, Sugita K, Morimoto C, Komiyama A (1995) CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 25:2825-2829
24. 24. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C (1995) CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci USA 92: 11249-11253
25. 25. Jacqout S, Kobata T, Iwata S, Morimoto C, Schlossman SF (1997) CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T-cell dependent B cell responses. J Immunol 159:2652-2657
26. 26. Lens SMA, de Jong R, Hooibrink B, Koopman G, Pals ST, van Oers MHJ, van Lier RAW (1996) Phenotype and functions of human B cells expressing CD70 (CD27L). Eur J Immunol 26:2964-2971
27. 27. Agematsu K, Nagumo H, Oguchi Y, Nakazawa T, Fukushima K, Yasui K, Ito S, Kobata T, Morimoto C, Komiyama A (1998) Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 91:173-180
28. + T lymphocytes. J Immunol 152:1523-1531
29. 29. Wiley SR, Goodwin RG, Smith CA (1996) Reverse signalling via CD30 ligand. J Immunol 157:3635-3639
30. 30. Pollok KE, Kim Y-J, Hurtado J, Kim KK, Kwon BS (1994) 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur J Immunol 24:367-374
31. 31. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W (1995) Cross-linking of OX40-ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507-521
32. 32. Hintzen RQ, Lens SM, Beckmann MP, Lynch D, Goodwin RG, van Lier RAW (1994) Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 152:1762-1773
33. 33. Bigler RD, Bushkin Y, Chiorazzi N (1988) S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol 141:21-28
34. 34. de Jong R, Loenen WAM, Brouwer M, van Emmerik L, De Vries EFR, Borst J, van Lier RAW (1991) Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors. J Immunol 146:2488-2494
35. 35. Prasad KVS, Ao Z, Yoon Y, Wu MX, Rizk M, Jacqout S, Schlossman SF (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 94:6346-6351
36. 36. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512
37. 37. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798
38. 38. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1-16
39. 39. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B (1995) RIP:a novel protein containing a death domain that interacts with FAS/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523
40. 40. Akiba H, Nakano H, Nischinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin N, Wallach D, Yagita H, Okumura K (1998) CD27, a member of the Tumor Necrosis Factor Receptor Superfamily, activates NF-κ B and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κ B-inducing kinase. J Biol Chem 273:13353-13358
41. 41. Gravestein LA, Amsen D, Boes M, Revilla Calvo C, Kruisbeek AM, Borst J (1998) The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol 28:2208-2216
42. 42. Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9
43. 43. Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692
44. 44. Rothe M, Sarma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424-1427
45. 45. Aizawa S, Nakano H, Ishida T, Horie R, Nagai M, Ito K, Yagita H, Okumura K, Inoue J, Watanabe T (1997) Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J Biol Chem 272:2042-2045
46. 46. Hsu H, Solovyev I, Colombero A, Elliot R, Kelley M, Boyle WJ (1997) ATAR, a novel tumor necrosis factor receptor family member, signals trough TRAF2 and TRAF5. J Biol Chem 272:13471-13474
47. 47. Arch RH, Thompson CB (1998) 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol 18:558-565
48. 48. Kawamata S, Hori T, Imura A, Takaori-Kondo A, Uchiyama T (1998) Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF)2-and TRAF-5-mediated NF-κ B activation. J Biol Chem 273:5808-5814
49. 49. Kashiwada M, Shirakata Y, Inoue JI, Nakano H, Okazaki K, Okumura K, Yamamoto T, Nagaoka H, Takemori T (1998) Tumor Necrosis Factor receptor-associated factor 6 (TRAF6) stimulates extracelluar signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J Exp Med 187:237-244
50. 50. Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J (1996) TRAF5, a novel tumor necrosis factor receptor-associated family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93:9437-9442
51. 51. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins. Cell 83:1243-1252
52. 52. Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C (1992) Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol 149:1199-1203
53. 53. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W (1990) CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 20:2679-2684
54. 54. Martorell J, Rojo I, Vilella R, Martinez-Carceres E, Vives J (1990) CD27 induction on thymocytes. J Immunol 145:1356-1363
55. 55. Gravestein LA, Van Ewijk W, Ossendorp F, Borst J (1996) CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development. J Exp Med 184:675-685
56. 56. Hintzen RQ, de Jong R, Lens SMA, Brouwer M, Baars P, van Lier RAW (1993) Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 151:2426-2435
57. 57. Hintzen RQ, van Lier RAW, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH (1991) Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 35:211-217
58. 58. De Rie MA, Hamerlinck F, Hintzen RQ, Bos JD, van Lier RAW (1991) Quantification of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis. Arch Dermatol Res 283:533-534
59. 59. Chamuleau MED, ten Berge IJM, Schellekens PTA, Wilmink JM, Hintzen RQ, van Lier RAW (1992) Serum levels of soluble CD27 in renal transplant recipients. Transplantation 54:932-936
60. 60. Yazdanbakhsh M, Sartono E, Kruize YCM, Kurniawan A, van der Pouw-Kraan T, Van der Meide PH, Selkirk ME, Partono F, Hintzen RQ, van Lier RAW, Maizels RM (1993) Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol 23:3312-3317
61. + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 22:993-999
62. + T cell population. J Immunol 154:17-25
63. - lymphocyte subpopulation. J Immunol 154:4294-4301
64. 64. De Rie MA, Cairo I, van Lier RAW, Bos JD (1996) Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin. Clin Exp Dermat 21:104-111
65. 65. Hol BEA, Hintzen RQ, van Lier RAW, Alberts C, Out TA, Jansen HM (1993) Soluble and cellular markers of T-cell activation in patients with pulmonary sarcoidosis. Am Rev Resp Dis 148:643-649
66. 66. Hamann D, Baars PA, Rep MHG, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RAW (1997) Phenotypic and functional separation of memory and effector human CD8pos T cells. J Exp Med 186:1407-1418
67. - T lymphocytes: antigenic and functional properties. J Immunol 150:1147-1159
68. 68. van Oers MHJ, Pals ST, Evers L, Van der Schoot CE, Koopman G, Bonfrer JMG, Hintzen RQ, Von dem Borne AEGKr, van Lier RAW (1993) Expression and release of CD27 in human malignancies. Blood 82:3430-3436
69. + B cells and helper T cells in immunoglobulin production. Eur J Immunol 27:2073-2079
70. + B lymphocyte subset. J Immunol 148:3700-3705
71. 71. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewski K, Kuppers R (1998) Somatic hypermutation in normal and transformed human B cells. Immunol Rev 162:261-280
72. 72. Tesselaar K, Gravestein LA, van Schijndel GMW, Borst J, van Lier RAW (1997) Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J Immunol 159:4959-4965
73. 73. Hintzen RQ, Lens SMA, Koopman G, Pals ST, Spits H, van Lier RAW (1994) CD70 represents the human ligand for CD27. Int Immunol 6:477-480
74. 74. Lens SMA, Baars PA, Hooibrink B, van Oers MHJ, van Lier RAW (1997) APC-derived signals determine expression levels of CD70 on primed T cells. Immunology 90:38-45
75. + T lymphocytes in rheumatoid arthritis: comment on the article by Kohem et al. Arthritis Rheum 40:1186-1188
76. 76. Brugnoni D, Airo P, Marino R, Notarangelo LD, van Lier RAW, Cattaneo R (1997) CD70 expression on T-cell subpopulations: study of normal individuals and patients with chronic immune activation. Immun Lett 55:99-104
77. 77. Agematsu K, Kobata T, Sugita K, Hirose T, Schlossman SF, Morimoto C (1995) Direct cellular communication between CD45RO and CD45RA T cell subsets via CD27/CD70. J Immunol 154:3627-3635
78. + T cells. Eur J Immunol 26:1700-1706
79. 79. Oshima H, Nakano H, Nohara C, Kobata T, Nakajima A, Jenkins NA, Gilbert D, Copeland NG, Muto T, Yagita H, Okumura K (1998) Characterization of murine CD70 by molecular cloning and mAb. Int Immunol 10:517-526
80. 80. Lens SMA, Keehnen RMJ, van Oers MHJ, van Lier RAW, Pals ST, Koopman G (1996) Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. Eur J Immunol 26:1007-1011
81. + B cell subset with phenotypical and functional characteristics of germinal center B cells. Eur J Immunol 26:1712-1719
82. 82. Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu Y-J (1997) Germinal center founder cells display propensity for apoptosis before onset of somatinc mutations. J Exp Med 185:563-571
83. 83. Arpin C, de Bouteiller O, Razanajaona D, Fugier-Vivier I, Briere F, Banchereau J, Lebecque S, Liu YJ (1998) The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression. J Exp Med 187:1169-1178
84. 84. O'Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I, Swiggard WJ, Pope M, Bhardwaj N (1993) Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 178:1067-1078
85. 85. van der Pouw-Kraan T, de Jong R, Aarden L (1993) Development of human Th1 and Th2 cytokine responses: The cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur J Immunol 23:1-5
86. 86. Ranheim EA, Kipps TJ (1995) Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 12:3556-3565
87. 87. Stein H, Schwarting R, Niedobitek G, Dallenbach F (1989) Cluster report: CDw70, in Leucocyte Typing IV (Knapp W et al, eds), pp. 446-449. Oxford University Press, Oxford.
88. 88. Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W, Young LS (1995) Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am J Pathol 147:1152-1160
89. 89. Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 11:191-212